In this regard, other STING agonists also enhanced the antitumor effect when combined with tumor vaccines, chemotherapy, or radiotherapy: such applications of STING agonists are expected to continue to expand.55 Moreover, the newly identified role of cGAS in the DNA damage response (DDR) widens the scope of immunotherapies (see below). The gene discussed is CGAS; the disease is neoplasm.